Entry Detail



General Information

Database ID:exR0004416
RNA Name:EIF4A1
RNA Type:mRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):7572706End Site(bp):7579006
External Links:ENSG00000161960



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCA2
chr9
137007234
137028922
-
ABCB8
chr7
151028422
151047782
+
ABRACL
chr6
139028745
139043302
+
AC004080.3
chr7
27163535
27180013
-
AC004922.1
chr7
99325879
99394653
+
AC004997.1
chr22
30285238
30299482
-
AC010463.1
chr19
17267418
17282966
+
AC011511.4
chr19
10315471
10320678
-
AC026464.4
chr16
69299682
69322700
+
AC048338.1
chr12
122207779
122266423
-
AC073896.1
chr12
56285916
56316059
-
AC092143.1
chr16
89919165
89936092
+
AC245033.1
chr15
82536788
82573194
-
ACSS3
chr12
80936414
81261210
+
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTN4
chr19
38647649
38731589
+
ADPGK
chr15
72751369
72785846
-
AFAP1
chr4
7758714
7939926
-
AGPAT1
chr6
32168212
32178096
-
AHCY
chr20
34280268
34311802
-
AK1
chr9
127866486
127877675
-
AKAP1
chr17
57085092
57121346
+
AL139300.1
chr14
103562962
103685924
+
ALDH18A1
chr10
95605941
95656711
-
ALDH7A1
chr5
126531200
126595362
-
ALDOA
chr16
30064164
30070457
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-28-5p
chr3
188688794
188688815
+
hsa-miR-129-5p
chr7
128207876
128207896
+
hsa-miR-330-5p
chr19
45639049
45639070
-
hsa-miR-1294
chr5
154347153
154347174
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC006064.5
chr12
6510275
6510522
+
AC007952.4
chr17
19112000
19112636
-
AC010542.4
chr16
66549280
66551189
+
AC016876.2
chr17
7581964
7584086
-
AC064802.1
chr8
114282067
114295839
+
AC132217.1
chr11
2129121
2129964
-
AC135050.5
chr16
31118078
31118747
+
AC245033.4
chr15
82533175
82540008
-
AD000090.1
chr19
35557956
35581954
+
AL008721.2
chr22
25476218
25479971
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.